DJ Bristol Myers Squibb Co. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. $(BMY)$ slid 2.51% to $61.35 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 1.03% to 7,340.53 and Dow Jones Industrial Average falling 1.64% to 50,759.42.
This was the stock's second consecutive day of losses.
Bristol Myers Squibb Co. closed 10.62% below its 52-week high of $68.64, which the company achieved on August 19th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ fell 1.36% to $278.70, Pfizer Inc. $(PFE)$ fell 1.35% to $28.47, and Abbott Laboratories $(ABT)$ fell 2.55% to $104.71.
Data source: Dow Jones Market Data, FactSet. Data compiled November 17, 2026.
Comments